New Stock Offerings - Jichuan Pharmaceutical (600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - *ST Yazhen (603389) has a tender offer period from June 10, 2025, to July 9, 2025[1] - Zhongcheng Tui (300208) has 11 trading days remaining until the last trading day[1] Delisting and Trading Reminders - Tui Shi Jin Gang (600190) has 11 trading days remaining until the last trading day[1] - Hengli Tui (000622) is in the delisting arrangement period with 8 trading days remaining[1] - Tui Shi Jiu You (600462) has 7 trading days remaining until the last trading day[1] Market Volatility - Beifang Changlong (301357) reported severe abnormal fluctuations[1] - Multiple companies, including Jichuan Pharmaceutical and *ST Yazhen, are under scrutiny for trading anomalies[1]

Market Overview - On July 2, the Shanghai Composite Index fell by 0.09%, with institutional investors appearing on the trading lists of 32 stocks, net buying 9 and net selling 23 [1][2] - The total net selling amount by institutional investors reached 641 million yuan [1] Institutional Trading Highlights - The stock with the highest net buying from institutional seats was Anglikang, which closed at the daily limit with a trading volume of 927 million yuan and a turnover rate of 11.45%, net buying amounting to 100.91 million yuan [2][5] - Feiya Technology also closed at the daily limit, with a trading volume of 1.549 billion yuan and a turnover rate of 23.87%, net buying 69.19 million yuan [2][5] - Xinhenghui saw a decline of 5.43% with a turnover rate of 47.06%, net buying 45.42 million yuan [2][5] Performance of Net Bought Stocks - Stocks that were net bought by institutions showed an average increase of 2.57%, outperforming the Shanghai Composite Index [3] - Stocks like Xiangqiang Co. and Kangda New Materials reported strong performances, closing at the daily limit [3] - Historical data indicates a 54.87% probability of net bought stocks rising the next day, with a 51.62% chance of outperforming the index [3] Earnings Forecasts - Among the stocks net bought by institutions, only one stock, Xinhenghui, provided a half-year earnings forecast, expecting a net profit of 106 million yuan, representing a year-on-year increase of 4.59% [3] Net Sold Stocks - The stock with the highest net selling was Changqing Technology, with a net selling amount of 177.81 million yuan, and a turnover rate of 56.72% [3][6] - North Copper, with a net selling of 102.36 million yuan, had a volatility of 16.01% [4][6] - Hongbaoli experienced a net selling of 79.41 million yuan, with a turnover rate of 46.13% [4][6] Southbound Trading Activity - On July 2, 19 stocks on the trading list had southbound trading activity, with net buying in stocks like Rongfa Nuclear Power and Kaimete Gas, amounting to 123 million yuan and 96.13 million yuan respectively [7][9] - Stocks like Hongye Futures and Xiexin Energy saw net selling amounts of 33.58 million yuan and 29.89 million yuan respectively [7][9]

Group 1 - The stock of Changqing Technology (603125) decreased by 2.12% today [1] - The trading volume reached 1.179 billion yuan, with a turnover rate of 56.72% [1] - The Shanghai Stock Connect special seat bought 16.1329 million yuan, while three institutional special seats net sold 178 million yuan [1]

Core Viewpoint - The stock price of Jiangsu Evergreen Tree New Materials Technology Co., Ltd. experienced an abnormal fluctuation, with a cumulative increase of 20% over two consecutive trading days on June 30 and July 1, 2025, prompting the company to clarify its operational status and confirm no undisclosed significant matters [2][3]. Group 1: Stock Trading Abnormalities - The company's stock price deviation reached a cumulative increase of 20% over two trading days, qualifying as an abnormal trading situation according to the Shanghai Stock Exchange rules [2][3]. - The company conducted a self-examination and confirmed that its operational status is normal, with no significant changes in market conditions or internal operations [3]. Group 2: Operational Status - The company reported that its production and operational conditions are stable, with no major adjustments in market environment or industry policies, and no significant fluctuations in production costs or sales [3][4]. - The previously disclosed announcement regarding the production of special polymer additives and electronic materials accurately reflects the project's operational status, although achieving full economic benefits will require time [3][4]. Group 3: Significant Matters - The company confirmed that there are no undisclosed significant matters related to major asset restructuring, share issuance, acquisitions, or other significant corporate actions as of the announcement date [4][9]. - There have been no media reports or market rumors identified that could significantly impact the company's stock price [5][8]. Group 4: Risk Awareness - The company emphasizes the importance of investor caution regarding market trading risks, given the significant short-term stock price fluctuations [7][8]. - The company reiterates that all information should be verified through its designated media channels to ensure accurate investment decisions [8].

Group 1 - The stock of Changqing Technology has hit the daily limit up for three consecutive trading days, with a current price of 21.30 yuan and a turnover rate of 3.60% [2] - During the continuous limit-up period, the stock has accumulated a rise of 33.13% and a cumulative turnover rate of 35.50% [2] - The latest total market capitalization of A-shares reached 8.623 billion yuan, with a circulating market capitalization of 2.156 billion yuan [2] Group 2 - As of July 1, the margin trading balance for the stock was 138 million yuan, with a financing balance of 138 million yuan, reflecting an increase of 17.77 million yuan or 14.78% from the previous trading day [2] - Over the past three days, the margin trading balance has increased by 11.69 million yuan, representing a growth of 9.26% [2] - The stock has appeared on the Dragon and Tiger list once due to a cumulative deviation of 20% in its price over three trading days, with institutional net selling of 44.9754 million yuan and a net buying of 23.4259 million yuan from brokerage seats [2] Group 3 - The company's Q1 report indicated total operating revenue of 246 million yuan, a year-on-year increase of 1.39%, while net profit was 35 million yuan, a year-on-year decrease of 23.80% [2] - Recent trading data shows fluctuations in daily price changes and net inflows of main funds, with notable net outflows on certain days [2]

江苏常青树新材料科技股份有限公司 经公司自查并向控股股东及实际控制人核实，截止本公告日，公司 经营情况正常，公司、公司控股股东及实际控制人不存在应披露而未披露的 重大事项。 证券代码：603125 证券简称：常青科技 公告编号：2025-045 江苏常青树新材料科技股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 内容提示： 江苏常青树新材料科技股份有限公司（以下简称"公司"）于 2025 年 6 月 30 日、7 月 1 日连续 2 个交易日内收盘价格涨幅偏离值累计达到 20%， 根据《上海证券交易所交易规则》有关规定，属于股票交易异常波动的情形。 重大风险提示： 公司此前在上海证券交易所网站（www.sse.com.cn）披露《关于特种聚 合材料助剂及电子专用材料制造项目投产的公告》（公告编号：2025-044） 真实、准确地反映了公司特种聚合材料助剂及电子专用材料制造项目（以下 简称"募投项目"）投产的情况，并揭示了市场变化不确定风险及项目效益 不达预期风险，公司敬请广大投资者注意二级市 ...

Core Viewpoint - The A-share market shows a mixed performance with 476 stocks breaking through the five-day moving average, indicating potential investment opportunities in certain sectors [1] Group 1: Market Overview - As of 10:29 AM, the Shanghai Composite Index is at 3432.93 points, below the five-day moving average, with a fluctuation of 0.25% [1] - The total trading volume of A-shares today is 693.146 billion yuan [1] Group 2: Stocks with Significant Deviation - The stocks with the largest deviation from the five-day moving average include: - Morningstar Aviation (晨曦航空) with a deviation of 15.14% and a price increase of 19.99% [2] - Qifeng Precision (七丰精工) with a deviation of 11.69% and a price increase of 15.15% [2] - Awatech (阿为特) with a deviation of 10.02% and a price increase of 14.90% [2] - Other notable stocks with significant price increases and deviations include: - Xiongtai Technology (雄帝科技) with an 11.52% increase and an 8.85% deviation [2] - Songsheng Co. (崧盛股份) with a 10.85% increase and an 8.36% deviation [2] Group 3: Additional Stocks with Positive Performance - Other stocks showing positive performance and deviations include: - Lijun Co. (利君股份) with a 9.97% increase and a 7.69% deviation [2] - Xiangyu Medical (翔宇医疗) with a 10.41% increase and a 7.66% deviation [2] - Chengfei Integration (成飞集成) with a 10.00% increase and a 7.58% deviation [2]

Group 1 - Hengbang Co., Ltd. plans to establish a joint venture with Huasheng Development with a registered capital of 10 million yuan, where Hengbang will contribute 8 million yuan (80%) and Huasheng will contribute 2 million yuan (20%) [1] - Hunan Gold's subsidiary Anhua Zhazi Creek Smelting Plant will undergo temporary maintenance starting from the end of June 2025, expected to last no more than 30 days [2] - Defu Technology's subsidiary signed supply agreements for lithium battery copper foil products with two leading global companies, with contract durations of 3 years and 5 years respectively [3] Group 2 - Binjiang Group won the rights to two residential land parcels for a total price of 4.368 billion yuan [5] - Zhong'an Technology announced the resignation of its executive vice president and board secretary due to personal reasons [7] - Changqing Technology's project for special polymer materials and electronic materials has officially commenced production, adding a capacity of 120,500 tons per year [10] Group 3 - Gansu Energy received approval from the China Securities Regulatory Commission to publicly issue bonds totaling up to 2 billion yuan [10] - Shuoshi Biology obtained a medical device registration certificate for an in vitro diagnostic reagent, valid until June 2030 [12] - Yawen Co., Ltd. plans to issue shares to specific investors, with the application accepted by the Shenzhen Stock Exchange [13] Group 4 - Guoyao Modern's subsidiary received approval for the listing of a raw material drug, which is a selective anticholinergic agent [16] - Inner Mongolia First Machinery's subsidiary signed a railway freight car procurement contract worth 130 million yuan [18] - Xining Special Steel plans to raise up to 1 billion yuan through a private placement to its controlling shareholder [39] Group 5 - Huadong Medicine's subsidiary received approval for a clinical trial of a new injectable drug targeting advanced solid tumors [29] - Warner Pharmaceutical's compound potassium hydrogen phosphate injection passed the consistency evaluation for generic drugs [30] - North Special Technology plans to raise up to 300 million yuan through a private placement for a production base project in Thailand [30] Group 6 - Xiangyang Technology is the first candidate for a 533 million yuan Airbus project [45] - Haishun New Materials intends to acquire 100% of Guangdong Zhengyi Packaging [46] - Jida Zhengyuan's shareholder plans to reduce their stake by up to 0.73% due to personal financial needs [47]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 项目进展情况 江苏常青树新材料科技股份有限公司（以下简称"公司"）首次公开发行股 票募集资金投资项目"特种聚合材料助剂及电子专用材料制造项目"（以下简称 "募投项目"）已于 2024 年 12 月进行了试生产，具体内容详见公司于 2024 年 12 月 7 日在上海证券交易所网站（www.sse.com.cn）披露的《江苏常青树新材 料科技股份有限公司关于特种聚合材料及电子专用材料制造项目试生产的公告》 （公告编号：2024-069）。截至本公告日，募投项目经过前期试生产，已完成对 生产工艺、机器设备的安装调试，相关生产线已于近日正式投产。 二、 对公司的影响 证券代码：603125 证券简称：常青科技 公告编号：2025-044 江苏常青树新材料科技股份有限公司 关于特种聚合材料助剂 及电子专用材料制造项目投产的公告 江苏常青树新材料科技股份有限公司 公司募投项目生产线的建成对公司实现发展战略具有重要意义，是公司坚持 创新、持续投入的成果。募投项目投产后，将新增特种单体及 ...

Group 1 - The core point of the article is that Changqing Technology (603125) has officially launched its fundraising project for the production of special polymer additives and electronic materials [1] - The project adds a total production capacity of 120,500 tons per year for special monomers and dedicated additives [1] - This initiative aims to enhance the company's product matrix, thereby improving its market competitiveness and sustainable development capabilities [1]